Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
10.65
-0.05 (-0.47%)
Mar 11, 2025, 4:00 PM EST - Market closed
Company Description
Exicure, Inc. does not have significant operations.
previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets.
Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Exicure, Inc.
| Country | United States |
| Founded | 2011 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Andy Yoo |
Contact Details
Address: 2430 North Halsted Street Chicago, Illinois 60614 United States | |
| Phone | 847 673 1700 |
| Website | exicuretx.com |
Stock Details
| Ticker Symbol | XCUR |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001698530 |
| CUSIP Number | 30205M101 |
| ISIN Number | US30205M2008 |
| Employer ID | 81-5333008 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Andy Yoo | Chief Executive Officer, President and Director |
| Seung Ik Baik | Chief Financial Officer, Secretary and Director |
| Joshua Miller | Chief Accounting Officer |
| Jiyoung Hwang | Chief Strategic Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 5, 2025 | 8-K | Current Report |
| Feb 21, 2025 | 8-K | Current Report |
| Jan 23, 2025 | 8-K/A | [Amend] Current report |
| Jan 22, 2025 | 8-K | Current Report |
| Jan 6, 2025 | 8-K | Current Report |
| Dec 26, 2024 | 8-K | Current Report |
| Dec 26, 2024 | 8-K/A | [Amend] Current report |
| Dec 23, 2024 | SCHEDULE 13G | Filing |
| Dec 20, 2024 | 8-K | Current Report |
| Dec 17, 2024 | 8-K | Current Report |